Company
EpiVax intends to utilize its scientific and technological assets related to epitope discovery, de-immunization, and vaccine design through a mix of collaborative and internal programs by applying the following business strategies.
Provide epitope discovery and de-immunization services to researchers and developers in both industry and academia
Establish collaborations with pharmaceutical, vaccine, and biotechnology companies, focused on biological targets chosen by the respective collaborators
Conduct internal discovery and design efforts aimed at selected biological targets, retaining a larger economic interest in the subsequently out-licensed lead candidates
Maintain technology leadership in both product development and rapid vaccine design capabilities through grant-funded R&D programs
CONTACT
Epivax, Inc.
location_on88 Valley Street, Suite 424, Providence, RI 02909, USA
local_phone1-401-272-2123
contact_mailinfo@epivax.com